Rob S. Beanlands

Comparison of computed tomographic angiography versus rubidium-82 positron emission tomography for the detection of patients with anatomical coronary artery disease.

Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure.

Prognostic value of treadmill exercise and dobutamine stress positron emission tomography.

Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography.

Right and left ventricular uptake with Rb-82 PET myocardial perfusion imaging: markers of left main or 3 vessel disease.

Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats.

In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome.

Radiosynthesis of N-[(11)C]-methyl-hydroxyfasudil as a new potential PET radiotracer for rho-kinases (ROCKs).

Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy.

Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity.

Effects of mitral valve surgery on myocardial energetics in patients with severe mitral regurgitation.

Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction.

18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.

Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program.

The clinical utility of assessing myocardial blood flow using positron emission tomography.

Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro.

Quantification of myocardial blood flow and flow reserve: Technical aspects.

Single-phase CT aligned to gated PET for respiratory motion correction in cardiac PET/CT.

Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features.

Assessment of myocardial ischaemia and viability: role of positron emission tomography.

Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.

PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.

Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET.

Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.

Radionuclide Imaging of Viable Myocardium: Is it Underutilized?

Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia.

Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats.

Rates of downstream invasive coronary angiography and revascularization: computed tomographic coronary angiography vs. Tc-99m single photon emission computed tomography.

Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment.

Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial.

Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.

PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.

The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.

Imaging the failing right ventricle.

Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension.

Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?

Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit.

(18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.

Measuring coronary artery calcification using positron emission tomography-computed tomography attenuation correction images.

Uniformity and repeatability of normal resting myocardial blood flow in rats using [13N]-ammonia and small animal PET.

A three-dimensional model-based partial volume correction strategy for gated cardiac mouse PET imaging.

Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now.

Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of coronary artery disease using 3D PET and normal database interpretation.

Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis.

Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.

Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study.

Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.

Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy.

Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation.

Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET.

Myocardial viability: whom, what, why, which, and how?

Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET/CT and a 1-tissue-compartment model of 82Rb kinetics.

Current and future clinical applications of cardiac positron emission tomography.

Corticosteroid therapy for cardiac sarcoidosis: a systematic review.

Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.

Test-retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography.

Epicardial adipose tissue thickness as a predictor of impaired microvascular function in patients with non-obstructive coronary artery disease.

Chronic AMPK activity dysregulation produces myocardial insulin resistance in the human Arg302Gln-PRKAG2 glycogen storage disease mouse model.

Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats.

Lessons from the Tc-99m shortage: implications of substituting Tl-201 for Tc-99m single-photon emission computed tomography.

Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?

Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.

Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Preclinical evaluation of biopolymer-delivered circulating angiogenic cells in a swine model of hibernating myocardium.

Cardiac PET: metabolic and functional imaging of the myocardium.

Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia.

Clinical interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI.

Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C).

Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients.

Prognostic value of PET myocardial perfusion imaging in obese patients.

Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.

The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium.

Reply: Noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG.

Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart.

Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study.

Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors.

Appropriate, quality imaging tests through linkage of payment to guidelines, accreditation and training.

Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant.

Myocardial viability: it is still alive.

Detection and severity classification of extracardiac interference in ⁸²Rb PET myocardial perfusion imaging.

Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease.

Single low-dose CT scan optimized for rest-stress PET attenuation correction and quantification of coronary artery calcium.

Obesity and the challenges of noninvasive imaging for the detection of coronary artery disease.

Advanced imaging of cardiac sarcoidosis.

PET imaging of a collagen matrix reveals its effective injection and targeted retention in a mouse model of myocardial infarction.

Development of reporter gene imaging techniques for long-term assessment of human circulating angiogenic cells.

Respiratory motion resulting in a pseudo-ischemia pattern on stress PET-CT imaging.

Test-retest repeatability of myocardial blood flow and infarct size using ¹¹C-acetate micro-PET imaging in mice.

Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.

Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.

The Journey of International Fellows: Have you been to America?

Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification.

Clinical PET Myocardial Perfusion Imaging and Flow Quantification.

Cardiac Sarcoidosis.

Patient motion effects on the quantification of regional myocardial blood flow with dynamic PET imaging.

Women Image Wisely: The 3 mSv Challenge for Nuclear Cardiology.

Characterization of 18F-FPyKYNE-Losartan for Imaging AT1 Receptors.

Imaging of cardiac sarcoidosis.

Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan.

Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation.

Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle?

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.

Cardiac Sarcoidosis.

The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.

False-positive stress PET-CT imaging in a patient with interstitial injection.

Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow.

Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.

Systemic and inflammatory disorders involving the heart: the role of PET imaging.

(82)Rb PET imaging of myocardial blood flow-have we achieved the 4 "R"s to support routine use?

Consistent tracer administration profile improves test-retest repeatability of myocardial blood flow quantification with Rb dynamic PET imaging.

Erratum to: American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET.

Role of 18F-Fluorodeoxyglucose/Positron Emission Tomography Imaging to Demonstrate Resolution of Acute Myocarditis.

Clinical PET Flow Reserve Imaging: Is There Precision to Treat Patients or Populations?

Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: A validation study and systematic review.

Can Functional Testing for Ischemia and Viability Guide Revascularization?

Optimally Repeatable Kinetic Model Variant for Myocardial Blood Flow Measurements with Rb PET.

Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity.

Lesion contrast recovery for partial-volume averaging: Quantitative correction or qualitative enhancement?

Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis.

False-positive N-ammonia positron emission tomography perfusion scan caused by misalignment of adjacent lung activity during attenuation correction.

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease.

Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.

Joint SNMMI-ASNC Expert Consensus Document on the Role of F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Joint SNMMI-ASNC expert consensus document on the role of F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Appropriate Use Criteria for Cardiac Computed Tomography: Does Computed Tomography Have Incremental Value in All Appropriate Use Criteria Categories?

N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.

Reporting myocardial flow reserve with PET. Ready or not, here it is! But walk before you fly!

Myocardial perfusion imaging: Lessons learned and work to be done-update.

Molecular Imaging for the diagnosis of infective endocarditis: A systematic literature review and meta-analysis.

Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.

Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body F-fluorodeoxyglucose positron emission tomography.

Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using C-acetate PET.

Role of plasminogen activator inhibitor-1 in coronary pathophysiology.

Optimizing Risk Stratification and Noninvasive Diagnosis of Ischemic Heart Disease in Women.

Saline-push improves rubidium-82 PET image quality.

PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.

Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging.

Reporting of coronary artery calcification on chest CT studies in breast cancer patients at high risk of cancer therapy related cardiac events.

Coronary artery microvascular dysfunction: Role of sex and arterial load.

[18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events.

Is There an Age When Myocardial Perfusion Imaging May No Longer Be Prognostically Useful?

Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging.

Effects of Riociguat on Right Ventricular Remodelling in Chronic Thromboembolic Pulmonary Hypertension Patients: A Prospective Study.

Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective.

PET imaging of sympathetic innervation with [F]Flurobenguan vs [C]mHED in a patient with ischemic cardiomyopathy.

Disability-free survival after coronary artery bypass grafting in women and men with heart failure.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Looking for trouble: Reduced myocardial flow reserve following anthracyclines.

What does the future hold for nuclear cardiology?

To the heart of the matter; a valentine's day to remember.

Is there a role for imaging heart teams? Looking forward together!

ASNC's global impact: Transforming nuclear cardiology and making the world smaller.

Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.

The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function.

Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.

Older patients with cardiovascular disease: A new frontier for nuclear cardiology?

Differential association of diabetes mellitus and female sex with impaired myocardial flow reserve across the spectrum of epicardial coronary disease.

Nuclear Cardiology, the Future is Now!

Effect of proton pump inhibitors on Rubidium-82 gastric uptake using positron emission tomography myocardial perfusion imaging.

Competency-Based Medical Education: Do the Cardiac Imaging Training Guidelines Have it Right?

Reliable quantification of myocardial sympathetic innervation and regional denervation using [C]meta-hydroxyephedrine PET.

Correction to: PET imaging of sympathetic innervation with [F]Flubrobenguane vs [C]mHED in a patient with ischemic cardiomyopathy.

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance.

Serial F-Fluorodeoxyglucose Positron Emission Tomography Imaging in a Patient With Giant Cell Myocarditis.

Comparison of coronary CT angiography versus functional imaging for CABG patients: A resource utilization analysis.

Reproducible Quantification of Regional Sympathetic Denervation with [C]meta-Hydroxyephedrine PET Imaging.

Increased myocardial oxygen consumption rates are associated with maladaptive right ventricular remodeling and decreased event-free survival in heart failure patients.

Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems.

Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography.

Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations.

The Future of Cardiac Molecular Imaging.

Age, Not Sex, Modifies the Effect of Frailty on Long-term Outcomes After Cardiac Surgery.

A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging.

Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C).

Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice.

Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.

PET Flow Quantification: An Arbitrator in Patients With Ischemic Cardiomyopathy?: The Jury Is Still Out.

Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation.

Regional Distribution of Fluorine-18-Flubrobenguane and Carbon-11-Hydroxyephedrine for Cardiac PET Imaging of Sympathetic Innervation.

Prognostic importance of coincidental coronary artery calcification on FDG-PET/CT oncology studies.

Sex-specific temporal trends in ambulatory heart failure incidence, mortality and hospitalisation in Ontario, Canada from 1994 to 2013: a population-based cohort study.

Exploring Occupational, Recreational, and Environmental Associations in Patients With Clinically Manifest Cardiac Sarcoidosis.

Internal validation of myocardial flow reserve PET imaging using stress/rest myocardial activity ratios with Rb-82 and N-13-ammonia.

Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process.

PET Assessment of Cardiac Allograft Vasculopathy.

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.

Persistent Lung Inflammation After Clinical Resolution of Community-Acquired Pneumonia as Measured by FDG-PET/CT Imaging.

Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis.

Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes.

Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy.

COUNTERPOINT: Should Isolated Cardiac Sarcoidosis Be Considered a Significant Manifestation of Sarcoidosis? No.

Rebuttal From Drs Birnie, Nery, and Beanlands.

Does quantification of [C]meta-hydroxyephedrine and [N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy.

Correction to: Does quantification of [C]meta-hydroxyephedrine and [N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy.

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review.

Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction.

Cardiac Sympathetic Positron Emission Tomography Imaging with -[F]Fluorobenzylguanidine is Sensitive to Uptake-1 in Rats.

ASNC's thoughts on the AHA/ACC chest pain guidelines.

Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study.

Diagnosis of unrecognized aortic dissection by hybrid PET/CT rubidium-82 imaging.

Static CT myocardial perfusion imaging: image quality, artifacts including distribution and diagnostic performance compared to Rb PET.

Metabolic activity of the left and right atria are differentially altered in patients with atrial fibrillation and LV dysfunction.

Finding the Road to Rome in Cardiac Allograft Vasculopathy Imaging Surveillance.